Enhanced immunogenicity and protective efficacy with the use of interleukin-12-encapsulated microspheres plus AS01B in tuberculosis subunit vaccination.
about
Particle-mediated delivery of cytokines for immunotherapyInterleukin 12B (IL12B) genetic variation and pulmonary tuberculosis: a study of cohorts from The Gambia, Guinea-Bissau, United States and ArgentinaCo-immunization of plasmid DNA encoding IL-12 and IL-18 with Bacillus Calmette-Guérin vaccine against progressive tuberculosisInterleukin-12 and tuberculosis: an old story revisitedImmunological options for the treatment of tuberculosis: evaluation of novel therapeutic approaches.Improving vaccines by incorporating immunological coadjuvants.Cytokine therapy of tuberculosis at the crossroads.Enhanced delivery efficiency of recombinant adenovirus into tumor and mesenchymal stem cells by a novel PTD.Treatment of multidrug-resistant and extensively drug-resistant tuberculosis: current status and future prospects.Synthetic nanovaccines for immunotherapy.Potential of polymeric particles as future vaccine delivery systems/adjuvants for parenteral and non-parenteral immunization against tuberculosis: A systematic review.Immunogenicity and protective efficacy conferred by a novel recombinant Mycobacterium bovis bacillus Calmette-Guérin strain expressing interleukin-12p70 of human cytokine and Ag85A of Mycobacterium tuberculosis fusion protein.Nanoparticle Vaccines Against Infectious Diseases
P2860
Q26997993-57AA100C-6341-453B-AC76-626A19811FF1Q33826089-7C824378-ECA5-4BF7-A1A6-0887DFD6CAEFQ35561894-98409FD2-A509-4EAF-A224-A1231FD579E6Q36137298-94A0AE34-466F-492A-9143-3B133E8BD1A4Q36839739-E06CD51E-77AE-4E94-A342-3DFEA22E65CAQ36899084-3085F493-BF17-4A99-9744-F5B0FAEB3BD5Q37754962-9784FDFF-3F09-4B7E-BEBD-8E96041E99EFQ39965322-CE469CDF-2A4A-478E-980F-EE4224CA170CQ39967041-3E4D2733-D68C-456A-A89B-ABEB4E37C925Q40280801-CDE29A58-F0F7-4D73-91F5-F88150A3F687Q49874317-8A770BC4-399D-4FC9-89F2-95D59A059C35Q54525914-B3B4F222-D413-4FA9-B489-4D6893A230B2Q58583890-DDCFD076-C36E-4774-B3F0-C1BECC2FD35A
P2860
Enhanced immunogenicity and protective efficacy with the use of interleukin-12-encapsulated microspheres plus AS01B in tuberculosis subunit vaccination.
description
2006 nî lūn-bûn
@nan
2006 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Enhanced immunogenicity and pr ...... erculosis subunit vaccination.
@ast
Enhanced immunogenicity and pr ...... erculosis subunit vaccination.
@en
Enhanced immunogenicity and pr ...... erculosis subunit vaccination.
@nl
type
label
Enhanced immunogenicity and pr ...... erculosis subunit vaccination.
@ast
Enhanced immunogenicity and pr ...... erculosis subunit vaccination.
@en
Enhanced immunogenicity and pr ...... erculosis subunit vaccination.
@nl
prefLabel
Enhanced immunogenicity and pr ...... erculosis subunit vaccination.
@ast
Enhanced immunogenicity and pr ...... erculosis subunit vaccination.
@en
Enhanced immunogenicity and pr ...... erculosis subunit vaccination.
@nl
P2093
P2860
P356
P1476
Enhanced immunogenicity and pr ...... erculosis subunit vaccination.
@en
P2093
Byong-Moon Kim
Eun-Gae Lee
Hyang-Ju Kang
Hye-Ju Kim
Sang-Jun Ha
Sang-Nae Cho
Seung-Chul Kim
Soon-Geon Kwon
Su-Hyung Park
Sung-Hee Lee
P2860
P304
P356
10.1128/IAI.01781-05
P407
P577
2006-08-01T00:00:00Z